Track the KESTRA MEDICAL TECHNOLOGIES, LTD. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €1.6bn. The latest transaction was disclosed on 18 August 2026 (Cession). Among the most active insiders: Webster Brian Daniel. The full history is openly available.
78
Insider Decl.
n/a
Thresholds
€968,610
4 ops.
Buy Volume
€7m
34 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate KESTRA MEDICAL TECHNOLOGIES, LTD. Strong Buy (bullish), based on 7 analysts. Average price target: US$30.00.
50Σ signal
Buys €968,610€7m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,272 of 28,985 companies
27.8
score / 100
Value
18
Quality
38
FCF yld-7.8%
Earn yld-8.8%
EV/EBITDA·
ROE-57%
Gross mgn51%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.